VENKYS (INDIA)
Back to Balance Sheet
|
VENKYS (INDIA) Last 5 Year Total Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹2,094 Cr | ₹2,015 Cr | ₹1,947 Cr | ₹1,790 Cr | ₹1,597 Cr |
What is the latest Total Liabilities ratio of VENKYS (INDIA) ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹2,094 Cr |
Mar2023 | ₹2,015 Cr |
Mar2022 | ₹1,947 Cr |
Mar2021 | ₹1,790 Cr |
Mar2020 | ₹1,597 Cr |
How is Total Liabilities of VENKYS (INDIA) Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹2,094 Cr | 3.91 | |
Mar2023 | ₹2,015 Cr | 3.51 | |
Mar2022 | ₹1,947 Cr | 8.77 | |
Mar2021 | ₹1,790 Cr | 12.04 | |
Mar2020 | ₹1,597 Cr | - |
Compare Total Liabilities of peers of VENKYS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENKYS (INDIA) | ₹2,094.5 Cr | 4.3% | -3.8% | -33.6% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹12,348.9 Cr | -5.2% | -9.3% | -28.7% | Stock Analytics | |
KAVERI SEED COMPANY | ₹5,891.6 Cr | 5.3% | 2% | 4.9% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,514.7 Cr | 8.3% | 6.2% | -27.6% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE | ₹480.8 Cr | -9.5% | -14% | NA | Stock Analytics | |
INDO US BIOTECH | ₹297.8 Cr | -2% | -10.7% | -43.2% | Stock Analytics |
VENKYS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENKYS (INDIA) | 4.3% |
-3.8% |
-33.6% |
SENSEX | -1.1% |
-1.7% |
-0.3% |
You may also like the below Video Courses